Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Images of medication Zepbound Generic Name tirzepatide Strength 12.5 mg/0.5 mL injection (single-dose vial) Availability Prescription only Drug Class GLP-1 Drugs CSA Schedule Not a controlled drug Labeler / Supplier Eli Lilly and Company National Drug Code (NDC) 00002-1423 More about Zepbound (tirzepatide) Check interactions Compare alternatives Pricing & coupons Reviews (726) Drug images Latest FDA alerts (3) Side effects Dosage information During pregnancy Support group FDA approval history Drug class: GLP-1 Drugs Breastfeeding En espaol Patient resources Other brands Professional resources Other brands Related treatment guides Further information Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
You may be eligible for Wegovy weight loss treatment if you meet one or more of the following criteria: You have a body mass index (BMI) of 30 or higher You have a BMI of 27 or higher with at least one weight-related health concern You have struggled to lose weight through diet and exercise alone You are looking for a medically guided, long-term weight management option You are committed to making lifestyle changes alongside treatment You do not have medical conditions that would make GLP-1based therapy unsuitable Eligibility is determined through a medical evaluation, which helps ensure Wegovy is a safe and appropriate option based on your health history and weight-loss goals
Potential benefits of taking semaglutide and phentermine together The main potential benefit of taking phentermine and semaglutide together is increased weight loss
GlyHisLysCu(II)
The researchers collected samples at study initiation, week 24, and week 48 from participants in the obesity trial
US$ 27.91
US$ 26.12
US$ 22.30
US$ 28.41
